Compounded tirzepatide

307 recorded programs, from $45 to $660 per month at each program's shortest published term. Sorted by that figure, lowest first. Terms and starting doses differ between programs, so read the term label on the entry before comparing two figures.

US route An FDA-approved tirzepatide product exists, but a compounded preparation is not itself an FDA-approved product. Compounding is permitted under section 503A. Recorded as of August 31, 2026. All tirzepatide forms.